Literature DB >> 7619614

Detectability of hypervascular hepatocellular carcinoma by arterial phase images of MR and spiral CT.

T Murakami1, T Kim, H Oi, H Nakamura, H Igarashi, M Matsushita, J Okamura, T Kozuka.   

Abstract

The ability of arterial phase images of breath-hold MR imaging and spiral CT to detect hypervascular hepatocellular carcinomas (HCCs) was evaluated. Prior to transcatheter arterial chemoembolization (TACE) with iodized oil, MR images and spiral CT during i.v. bolus injection of contrast medium (IV-MR imaging and IV-spiral CT) and spiral CT during intraarterial injection of contrast media through catheter (IA-spiral CT) of the entire liver were obtained in 24 consecutive patients with 93 HCCs. In the detection of HCCs less than 1 cm in diameter, IA-spiral CT (87.3%) was superior to IV-MR imaging (63.5%) and IV-spiral CT (54.0%) (p < 0.001). There was no significant difference in detectability in any tumor size between IV-MR imaging and IV-spiral CT. IA-spiral CT was the best for detecting hypervascular HCCs, and there was no significant difference between IV-MR imaging and IV-spiral CT.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7619614

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  6 in total

Review 1.  Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma.

Authors:  Jorge Filmus; Mariana Capurro
Journal:  Mol Diagn       Date:  2004

Review 2.  Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.

Authors:  Yu-Cheng Zhang; Zhuo Xu; Tian-Fu Zhang; Ya-Li Wang
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

3.  Imaging of hepatocellular carcinoma patient-derived xenografts using ⁸⁹Zr-labeled anti-glypican-3 monoclonal antibody.

Authors:  Xiaoyang Yang; Hongguang Liu; Chris K Sun; Arutselvan Natarajan; Xiang Hu; Xiaolin Wang; Mark Allegretta; Ronald D Guttmann; Sanjiv S Gambhir; Mei-Sze Chua; Zhen Cheng; Samuel K So
Journal:  Biomaterials       Date:  2014-05-16       Impact factor: 12.479

4.  Hepatocellular carcinoma - issues in imaging.

Authors:  C H Thng; Y T Kuo
Journal:  Cancer Imaging       Date:  2004-10-20       Impact factor: 3.909

5.  Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma.

Authors:  Hongwei Wang; Lijuan Hou; Aihui Li; Yuxiu Duan; Haili Gao; Xinwen Song
Journal:  Biomed Res Int       Date:  2014-05-18       Impact factor: 3.411

6.  Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis.

Authors:  Zhen Qu; Junhua Wu; Junyi Wu; Anlai Ji; Guanghui Qiang; Yong Jiang; Chunping Jiang; Yitao Ding
Journal:  Oncotarget       Date:  2017-09-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.